Neovasc adds two co-inventors to heart valve patents
23-04-2019
Federal Circuit affirms district court’s Bayer ruling
02-03-2017
05-09-2017
BCFC / iStockphoto.com
The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit, District Court of Massachusetts, CardiAQ, Neovasc, Arshad Quadri, Brent Ratz, medical devices